Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 1201 AL 1215

Influence of genetic and cardiometabolic risk factors in Alzheimer's disease

Pasqualetti G, Thayanandan T, Edison P.

Ageing Res Rev. 2022 Nov;81:101723. doi: 10.1016/j.arr.2022.101723. Epub 2022 Aug 28.

Cognitive and behavioral involvement in ALS has been known for more than a century

Zago S, Lorusso L, Aiello EN, Ugolini M, Poletti B, Ticozzi N, Silani V.

Neurol Sci. 2022 Dec;43(12):6741-6760. doi: 10.1007/s10072-022-06340-0. Epub 2022 Sep 2.

Volume, scope, and consideration of ethical issues in Indigenous cognitive impairment and dementia research: A systematic scoping review of studies published between 2000-2021

Bryant J, Freund M, Ries N, Garvey G, McGhie A, Zucca A, Hoberg H, Passey M, Sanson-Fisher R.

Dementia (London). 2022 Nov;21(8):2647-2676. doi: 10.1177/14713012221119594. Epub 2022 Sep 2.

A predictive coding framework of allostatic-interoceptive overload in frontotemporal dementia

Migeot JA, Duran-Aniotz CA, Signorelli CM, Piguet O, Ibáñez A.

Trends Neurosci. 2022 Nov;45(11):838-853. doi: 10.1016/j.tins.2022.08.005. Epub 2022 Sep 1.

Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies

Lu LY, Wu MY, Kao YS, Hung CH.

Clin Mol Hepatol. 2022 Oct;28(4):931-932. doi: 10.3350/cmh.2022.0259. Epub 2022 Sep 5.

Effect of renin-angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look AHEAD) trial

Wharton W, Anderson A, Hayden KM, Carmichael OT, Clark JM, Luchsinger JA, Espeland M, Yasar S.

Diabetes Obes Metab. 2022 Dec;24(12):2443-2453. doi: 10.1111/dom.14838. Epub 2022 Sep 5.

Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial

Whitfield T, Demnitz-King H, Schlosser M, Barnhofer T, Frison E, Coll-Padros N, Dautricourt S, Requier F, Delarue M, Gonneaud J, Klimecki OM, Lutz A, Paly L, Salmon E, Schild AK, Walker Z, Jessen F, Chételat G, Collette F, Wirth M, Marchant NL; Medit-Ageing Research Group.

Alzheimers Res Ther. 2022 Sep 6;14(1):125. doi: 10.1186/s13195-022-01057-w.

Periodontal health, cognitive decline, and dementia: A systematic review and meta-analysis of longitudinal studies

Asher S, Stephen R, Mäntylä P, Suominen AL, Solomon A.

J Am Geriatr Soc. 2022 Sep;70(9):2695-2709. doi: 10.1111/jgs.17978. Epub 2022 Sep 8.

Semantic variant primary progressive aphasia with a pathogenic variant p.Asp40Gly in the ANXA11 gene

Kim EJ, Moon SY, Kim HJ, Jung NY, Lee SM, Kim YE.

Eur J Neurol. 2022 Oct;29(10):3124-3126. doi: 10.1111/ene.15455.

Microbiota alteration and modulation in Alzheimer's disease by gerobiotics: The gut-health axis for a good mind

Ağagündüz D, Kocaadam-Bozkurt B, Bozkurt O, Sharma H, Esposito R, Özoğul F, Capasso R.

Biomed Pharmacother. 2022 Sep;153:113430. doi: 10.1016/j.biopha.2022.113430. Epub 2022 Jul 18.

NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol

Scuteri D, Guida F, Boccella S, Luongo L, Maione S, Tonin P, Nicotera P, Bagetta G, Corasaniti MT.

Biomed Pharmacother. 2022 Sep;153:113488. doi: 10.1016/j.biopha.2022.113488. Epub 2022 Aug 4.

Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease

Nordestgaard LT, Christoffersen M, Frikke-Schmidt R.

Int J Mol Sci. 2022 Aug 29;23(17):9777. doi: 10.3390/ijms23179777.

Everyday Experiences of People Living with Mild Cognitive Impairment or Dementia: A Scoping Review

Huizenga J, Scheffelaar A, Fruijtier A, Wilken JP, Bleijenberg N, Van Regenmortel T.

Int J Environ Res Public Health. 2022 Aug 30;19(17):10828. doi: 10.3390/ijerph191710828.

Reshaping the path of mild cognitive impairment by refining exercise prescription: a study protocol of a randomized controlled trial to understand the "what," "for whom," and "how" of exercise to promote cognitive function

Barha CK, Falck RS, Best JR, Nagamatsu LS, Hsiung GR, Sheel AW, Hsu CL, Kramer AF, Voss MW, Erickson KI, Davis JC, Shoemaker JK, Boyd L, Crockett RA, Ten Brinke L, Bherer L, Singer J, Galea LAM, Jacova C, Bullock A, Grant S, Liu-Ambrose T.

Trials. 2022 Sep 9;23(1):766. doi: 10.1186/s13063-022-06699-7.

Alzheimer's disease genes and proteins associated with resistance and aerobic training: An in silico analysis

Coutinho LA, Leão LL, Cassilhas RC, de Paula AMB, Deslandes AC, Monteiro-Junior RS.

Exp Gerontol. 2022 Oct 15;168:111948. doi: 10.1016/j.exger.2022.111948. Epub 2022 Sep 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias